Loss of RhoGDI is a novel independent prognostic factor in hepatocellular carcinoma

International Journal of Clinical and Experimental Pathology

Volumn 6, Issue 11, 2013, Pages 2535-2541

  Li, Weidong ^a   Wang, Hui ^a   Jin, Xuejun ^a   Zhao, Liang ^b  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Poor prognosis; Rho GDP dissociation inhibitor alpha

Indexed keywords

ARHGDIA PROTEIN, HUMAN; RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR 1; TUMOR MARKER;

ARTICLE; CHEMISTRY; DOWN REGULATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; POOR PROGNOSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RHO GDP-DISSOCIATION INHIBITOR ALPHA; RISK FACTOR;

HEPATOCELLULAR CARCINOMA; POOR PROGNOSIS; RHO GDP-DISSOCIATION INHIBITOR ALPHA;

CARCINOMA, HEPATOCELLULAR; DOWN-REGULATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR ALPHA; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84887109570     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Okuda K. Hepatocellular carcinoma. J Hepatol 2000;32:225-237.
2. El-Serag HB and Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-750.
3. Chiriva-Internati M, Grizzi F, Wachtel MS, Jenkins M, Ferrari R, Cobos E and Frezza EE. Biological treatment for liver tumor and new potential biomarkers. Dig Dis Sci 2008;53:836-843.
4. Golovanov AP, Chuang TH, DerMardirossian C, Barsukov I, Hawkins D, Badii R, Bokoch GM, Lian LY and Roberts GC. Structure-activity relationships in flexible protein domains:regulation of rho GTPases by RhoGDI and D4 GDI. J Mol Biol 2001;305:121-135.
5. Hoffman GR, Nassar N and Cerione RA. Structure of the Rho family GTP-binding protein Cdc42 in complex with the multifunctional regulator RhoGDI. Cell 2000;100:345-356.
6. Grizot S, Faure J, Fieschi F, Vignais PV, Dagher MC and Pebay-Peyroula E. Crystal structure of the Rac1-RhoGDI complex involved in nadph oxidase activation. Biochemistry 2001;40:10007-10013.
7. Olofsson B. Rho guanine dissociation inhibitors: pivotal molecules in cellular signalling. Cell Signal 1999;11:545-554.
8. Dovas A and Couchman JR. RhoGDI:multiple functions in the regulation of Rho family GTPase activities. Biochem J 2005;390:1-9.
9. Gildea JJ, Seraj MJ, Oxford G, Harding MA, Hampton GM, Moskaluk CA, Frierson HF, Conaway MR and Theodorescu D. RhoGDI2 is an invasion and metastasis suppressor gene in human cancer. Cancer Res 2002;62:6418-6423.
10. Jiang WG, Watkins G, Lane J, Cunnick GH, Douglas-Jones A, Mokbel K and Mansel RE. Prognostic value of rho GTPases and rho guanine nucleotide dissociation inhibitors in human breast cancers. Clin Cancer Res 2003;9:6432-6440.
11. Jones MB, Krutzsch H, Shu H, Zhao Y, Liotta LA, Kohn EC and Petricoin EF 3rd. Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer. Proteomics 2002;2:76-84.
12. Kasper B, Tidow N, Grothues D and Welte K. Differential expression and regulation of GTPases (RhoA and Rac2) and GDIs (LyGDI and RhoGDI) in neutrophils from patients with severe congenital neutropenia. Blood 2000;95:2947-2953.
13. Zhao L, Wang H, Sun X and Ding Y. Comparative proteomic analysis identifies proteins associated with the development and progression of colorectal carcinoma. FEBS J 2010;277:4195-4204.
14. Zhao L, Wang H, Li J, Liu Y and Ding Y. Overexpression of Rho GDP-dissociation inhibitor alpha is associated with tumor progression and poor prognosis of colorectal cancer. J Proteome Res 2008;7:3994-4003.
15. Ding J, Huang S, Wu S, Zhao Y, Liang L, Yan M, Ge C, Yao J, Chen T, Wan D, Wang H, Gu J, Yao M, Li J, Tu H and He X. Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA. Nat Cell Biol 2010;12:390-399.
16. Zhao L, Wang H, Liu C, Liu Y, Wang X, Wang S, Sun X, Li J, Deng Y, Jiang Y and Ding Y. Promotion of colorectal cancer growth and metastasis by the LIM and SH3 domain protein 1. Gut 2010;59:1226-1235.
17. Coppola D, Szabo M, Boulware D, Muraca P, Alsarraj M, Chambers AF and Yeatman TJ. Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies. Clin Cancer Res 2004;10:184-190.
18. Nobes CD and Hall A. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 1995;81:53-62.
19. Etienne-Manneville S and Hall A. Rho GTPases in cell biology. Nature 2002;420:629-635.
20. Faure J and Dagher MC. Interactions between Rho GTPases and Rho GDP dissociation inhibitor (Rho-GDI). Biochimie 2001;83:409-414.
21. DerMardirossian C and Bokoch GM. GDIs:central regulatory molecules in Rho GTPase activation. Trends Cell Biol 2005;15:356-363.
22. Ueda T, Kikuchi A, Ohga N, Yamamoto J and Takai Y. Purification and characterization from bovine brain cytosol of a novel regulatory protein inhibiting the dissociation of GDP from and the subsequent binding of GTP to rhoB p20, a ras p21-like GTP-binding protein. J Biol Chem 1990;265:9373-9380.
23. Fukumoto Y, Kaibuchi K, Hori Y, Fujioka H, Araki S, Ueda T, Kikuchi A and Takai Y. Molecular cloning and characterization of a novel type of regulatory protein (GDI) for the rho proteins, ras p21-like small GTP-binding proteins. Oncogene 1990;5:1321-1328.
24. Lelias JM, Adra CN, Wulf GM, Guillemot JC, Khagad M, Caput D and Lim B. cDNA cloning of a human mRNA preferentially expressed in hematopoietic cells and with homology to a GDP-dissociation inhibitor for the rho GTP-binding proteins. Proc Natl Acad Sci USA 1993;90:1479-1483.
25. Scherle P, Behrens T and Staudt LM. Ly-GDI, a GDP-dissociation inhibitor of the RhoA GTP-binding protein, is expressed preferentially in lymphocytes. Proc Natl Acad Sci USA 1993;90:7568-7572.
26. Adra CN, Manor D, Ko JL, Zhu S, Horiuchi T, Van Aelst L, Cerione RA and Lim B. RhoGDIgamma: a GDP-dissociation inhibitor for Rho proteins with preferential expression in brain and pancreas. Proc Natl Acad Sci USA 1997;94:4279-4284.
27. Zalcman G, Closson V, Camonis J, Honore N, Rousseau-Merck MF, Tavitian A and Olofsson B. RhoGDI-3 is a new GDP dissociation inhibitor (GDI). Identification of a non-cytosolic GDI protein interacting with the small GTP-binding proteins RhoB and RhoG. J Biol Chem 1996;271:30366-30374.